Choline kinase is upregulated in prostate cancer, resulting in increased 18F-
fluoromethylcholine uptake. This study used pharmacokinetic modeling to validate the use of …

Repeatable quantification is essential when using 18F-fluoromethylcholine PET/CT to
monitor treatment response in prostate cancer. It has been shown that SUV normalized to …

Radiolabeled prostate-specific membrane antigen (PSMA) PET has demonstrated
promising results for prostate cancer (PCa) imaging. Quantification of PSMA radiotracer …

The aim of this study was to investigate the value of pharmacokinetic modeling for
quantifying 11C-choline uptake in patients with recurrent prostate cancer. Methods: In total …

Background The use of radiolabeled choline as a positron emission tomography (PET)
agent for imaging primary tumors in the prostate has been evaluated extensively over the …

PET with 18F-choline (18F-FCH) is used in the diagnosis of prostate cancer and its
recurrences. In this work, biodistribution data from a recent study conducted at Skåne …

544 Objectives: To develop a completely automated method to quantify prostate gland
uptake of 18F-choline in PET/CT images and to study the relationship between this …

Aim The aim of the study was to compare the kinetic analysis of 18 F-labeled choline (FCH)
uptake with static analysis and clinicopathological parameters in patients with newly …

Abstract Purpose 18 F-Fluoroethylcholine (18 F-FECh) is excreted via the urinary system
with high activity accumulation in the urinary bladder. Furosemide and oral hydration can be …

18F-fluorodihydrotestosterone (18F-FDHT) PET/CT potentially provides a noninvasive
method for assessment of androgen receptor expression in patients with metastatic …